Overview Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults Status: Completed Trial end date: 2021-03-09 Target enrollment: Participant gender: Summary To evaluate the safety and pharmacokinetic characteristics of AJU-A51 in healthy adults Phase: Phase 1 Details Lead Sponsor: AJU Pharm Co., Ltd.